Together with our GLP-1 Companion Program, these tools help deliver powerful results, not just in near-term weight loss but in creating lasting habits that truly make a difference in long-term health." About Noom: Noom is a digital healthcare company empowering everyone, everywhere to live better longer, through an unwavering commitment to innovation and whole-person health
Apart from trials supporting the two opinions mentioned above, other results denied the possible impact of GLP-1RAs on DR
At present, there is a balance payers must achieve across a variety of influencing factors on whether to cover GLP-1s (see Figure 1)
As the WL achieved with the novel obesity pharmacotherapies approaches that of bariatric surgery, we will need to assess whether long-term complications observed after bariatric surgery such as increased risk of osteoporosis, fractures, macro- and micronutrient deficiencies as well as self-harm behaviours will also be present with pharmacotherapy [112, 113]
Retrieved from Eli Lilly and Company
Need a different vial size